Abstract
Background: The incidence of HPV-associated head and neck cancers, especially in the oropharyngeal region, is rising sharply, raising substantial clinical and public health concerns. These cancers are distinct from those caused by other etiologies such as tobacco and alcohol due to the unique prognosis of HPV-positive cases. Despite their generally better prognosis, there is significant uncertainty regarding the variation in survival outcomes between genders. This study aims to closely examine and understand gender differences in survival rates among patients with HPV-associated head and neck cancers, exploring potential disparities to inform treatment strategies and improve patient outcomes.
Methods: A systematic review and meta-analysis were conducted using data from 13 studies involving 203,346 HNC patients. The studies were sourced from PubMed, Embase, and Web of Science, covering research until May 2024. The analysis involved calculating pooled hazard ratios (HRs) for survival, assessing heterogeneity and publication bias using the I² statistic, funnel plots, and Egger’s test.
Results: The findings showed a slight, non-significant survival advantage for females in HPV-positive HNCs (HR 0.952). In HPV-negative HNCs, there was also no significant gender difference in survival (HR 1.053). The study noted high heterogeneity and significant publication bias.
Conclusions: No significant gender disparities in survival for HPV-positive or HPV-negative HNCs, suggesting the need for personalized care strategies beyond gender considerations.
Keywords:
Gender disparities, survival rates, HPV, head and neck cancer, systematic review, meta-analysisReferences
1. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70.
2. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
3. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-9.
4. Gaeta A, Tagliabue M, D'Ecclesiis O, Ghiani L, Maugeri P, De Berardinis R, et al. Are sex and gender considered in head and neck cancer clinical studies? NPJ Precis Oncol. 2023;7(1):84.
5. Amini A, Jasem J, Jones BL, Robin TP, McDermott JD, Bhatia S, et al. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Oral oncology. 2016;56:1-7.
6. Baliga S, Mitchell D, Yildiz VO, Gogineni E, Konieczkowski DJ, Grecula J, et al. Disparities in survival outcomes among Black patients with HPV‐associated oropharyngeal cancer. Journal of Medical Virology. 2023;95(2):e28448.
7. Faraji F, Rettig EM, Tsai HL, El Asmar M, Fung N, Eisele DW, Fakhry C. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status. Cancer. 2019;125(5):761-9.
8. Preissner SH, Nahles S, Preissner S, Heiland M, Koerdt S. Influence of sex on survival rates of HPV-positive oropharyngeal cancers. Frontiers in Oncology. 2022;12:917890.
9. Yin LX, D'Souza G, Westra WH, Wang SJ, van Zante A, Zhang Y, et al. Prognostic factors for human papillomavirus–positive and negative oropharyngeal carcinomas. The Laryngoscope. 2018;128(8):E288-E96.
10. Li H, Park HS, Osborn HA, Judson BL. Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers of the Head & Neck. 2018;3:1-12.
11. Roman BR, Aragones A. Epidemiology and incidence of HPV-related cancers of the head and neck. J Surg Oncol. 2021;124(6):920-2.
12. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261-9.
13. Langan D, Higgins JP, Jackson D, Bowden J, Veroniki AA, Kontopantelis E, et al. A comparison of heterogeneity variance estimators in simulated random‐effects meta‐analyses. Research synthesis methods. 2019;10(1):83-98.
14. Gandhi AP, Shamim MA, Padhi BK. Steps in undertaking meta-analysis and addressing heterogeneity in meta-analysis. The Evidence. 2023;1(1):44-59.
15. Berger MH, Yasaka TM, Haidar YM, Kuan EC, Tjoa T. Insurance status as a predictor of treatment in human papillomavirus positive oropharyngeal cancer. The Laryngoscope. 2021;131(4):776-81.
16. Goodman MT, Saraiya M, Thompson TD, Steinau M, Hernandez BY, Lynch CF, et al. Human papillomavirus genotype and oropharynx cancer survival in the United States of America. European journal of cancer. 2015;51(18):2759-67.
17. Kao DD, Ferrandino RM, Marshall DC, Mutetwa T, Miles B, Bauml JM, Sigel KM. Sex-related differences in outcomes for oropharyngeal squamous cell carcinoma by HPV status. International Journal of Otolaryngology. 2022;2022.
18. Sheth S, Farquhar DR, Lenze NR, Mazul A, Brennan P, Anantharaman D, et al. Decreased overall survival in black patients with HPV-associated oropharyngeal cancer. American journal of otolaryngology. 2021;42(1):102780.
19. Wookey VB, Appiah AK, Kallam A, Ernani V, Smith LM, Ganti AK. HPV status and survival in non-oropharyngeal squamous cell carcinoma of the head and neck. Anticancer research. 2019;39(4):1907-14.
20. Abdel-Rahman O. Sex-based differences in outcomes of patients with HPV-positive versus HPV-negative oropharyngeal carcinoma: a population-based study. Expert Rev Anticancer Ther. 2020;20(9):813-8.
21. Wu Q, Wang M, Liu Y, Wang X, Li Y, Hu X, et al. HPV positive status is a favorable prognostic factor in non-nasopharyngeal head and neck squamous cell carcinoma patients: a retrospective study from the surveillance, epidemiology, and end results database. Frontiers in oncology. 2021;11:688615.
22. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233(9):780-6.
How to Cite
License
Copyright (c) 2025 Ganesh Bushi, Sharath Hullumani, Pavithra Murugesan, Prity Rani Deshwal, Dhruv Kapoor, Shikha Yadav, Iko Musa, Priyanka Singla, Gadi Venkatesh, Farwa Fatima, Harish T, Nandhni Chiruganam Gandhi, Vinusha Raja Annamalai, Thara S, Srinisha Krishnamoorthy, Varshini S
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright© by the author(s). Published by the Evidence Journals. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Similar Articles
- Mona Thangamma AG , Shree Rath, Andria J N Sirur , Vijaya kumar Uthakalla, Santenna Chenchula , Swati Misra, Tuhin James Paulo , Debopriya, Chanchal Goyal , Ujjawal Sharma , G Vinod , Firdaus Samad, Arindam Biswas , Sree Sudha T Y, Cost Effectiveness of Fruquintinib for Colorectal Cancer: A systematic review , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Ankita Gaonkar , Shree Rath, Rahini S, Manav Jain, Raman Swathy Vaman, Anindita Das , Samiya Manal, Divjot Singh Lamba, Purnoor Kaur , SUKRITI YADAV , Sanjev Dave , Ashlesha Ashok Tawde, Swati Misra, Sowmisri BM , Chanchal Goyal , Shreekant Bharti , Krishna Chaitanya Amerneni, Transforming medical diagnosis: a comprehensive review of AI and ML technologies , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Ashutosh Jena, Jayalakshmi Rajeev, Divjot Singh Lamba, Shilpa DM , Priyanka Singla, Burden and trends of nutritional deficiencies among reproductive-age women in India (1990–2021): implications for sustainable public health strategies from the Global Burden of Disease Study 2021 , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Shubham Chauhan, Shilpa DM , Vighnesh Devulapalli, Shweta Pattnaik, Hearing Loss Prevalence, Years Lived with Disability, in South Asia from 1990 to 2021: An analysis from the Global Burden of Disease Study 2021 , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Aqsa Kiran, Ali Davod, Mark Cortnage, Richard Hayhoe, Russell Kabir, Risk factors associated with the onset of type 2 diabetes in Generation Z in the United Kingdom , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Ayesha, Ali Davod Parsa, Mark Cortnage, Richard Hayhoe, Ahmad Neyazi, Russell Kabir, Breastfeeding practices and contributing factors among Afghan women: insights from the MICS Survey , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Prasanna Srinivasan Ramalingam , Rajashekar Rao Barkur, Manjisa Choudhury, Priyanka Singla, Pavan Kumar , Prabhat, Ranjit Sah, Advancing genomic frontiers: emerging trends and transformative technologies in next-generation sequencing and computational analysis , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Muskan Sadik Kaliwala, Ali Davod, Mark Cortnage, Richard Hayhoe, Mehrab Neyazi, Russell Kabir, Menstruation and its effects on women’s mobility and social engagement in Afghanistan: insights from the 2022-2023 MICS survey , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Malathi Mini, Jomon De Joseph, Prabhat, Jagdish Khubchandani, Quantifying the economic burden of road traffic injuries in South Asia: a human capital approach , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Senthil Thirusangu, Janet Prameela Dsouza, Sumana Mukhopadhyay , Abdullahi Saminu , Tathagata jha, Prabhat, Aroop Mohanty, Revolutionizing antiviral therapies: the promise of nucleic acid-based interventions , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Ashutosh Jena, Jayalakshmi Rajeev, Divjot Singh Lamba, Shilpa DM , Priyanka Singla, Burden and trends of nutritional deficiencies among reproductive-age women in India (1990–2021): implications for sustainable public health strategies from the Global Burden of Disease Study 2021 , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
- Prasanna Srinivasan Ramalingam , Rajashekar Rao Barkur, Manjisa Choudhury, Priyanka Singla, Pavan Kumar , Prabhat, Ranjit Sah, Advancing genomic frontiers: emerging trends and transformative technologies in next-generation sequencing and computational analysis , Evidence Public Health: Vol. 1 No. 1 (2025): JAN-MAR
